(197 days)
No
The device description and performance studies focus on the mechanical function of a manual surgical instrument for tissue fixation. There is no mention of AI, ML, image processing, or data analysis that would indicate the use of such technologies.
No
The device is described as a surgical instrument for fixation of prosthetic material, not for directly treating a disease or condition.
No
The FasTouch Fixation System is described as a manual laparoscopic surgical instrument intended for fixation of prosthetic material to soft tissues. Its purpose is to physically attach materials, not to diagnose conditions or process diagnostic information.
No
The device description explicitly states it is a "manual laparoscopic surgical instrument" and describes physical components like a handle and cartridge, indicating it is a hardware device. The performance studies also focus on bench testing, animal testing, and biocompatibility, which are typical for hardware medical devices.
Based on the provided information, the FasTouch Fixation System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is for the "fixation of prosthetic material to soft tissues in various minimally invasive and open surgical procedures such as hernia repairs." This describes a surgical procedure performed on the patient's body, not a test performed on a sample taken from the patient's body.
- Device Description: The device is described as a "manual laparoscopic surgical instrument" used to "facilitate fixation of prosthetic material to soft tissue." This further reinforces its role as a surgical tool used during a procedure.
- Lack of IVD Characteristics: There is no mention of the device being used to analyze biological samples (blood, urine, tissue, etc.) or to provide diagnostic information about a patient's condition.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The FasTouch Fixation System does not fit this description.
N/A
Intended Use / Indications for Use
The FasTouch Fixation System is intended for fixation of prosthetic material to soft tissues in various minimally invasive and open surgical procedures such as hernia repairs.
Product codes
GDW
Device Description
The FasTouch Fixation System is a manual laparoscopic surgical instrument which is intended to facilitate fixation of prosthetic material to soft tissue in laparoscopic or open surgical procedures such as ventral hernia repair. The FasTouch Fixation System is disposable, single-use system.
The Via Surgical's FasTouch Fixation System is designed to be inserted through a laparoscopic port sleeve but may be used during open surgical procedures as well. The FasTouch Fixation System is packaged in its unloaded state and contains a handle and a cartridge.
The FasTouch Handle is a multi-fire, sterile, single-use handle that is compatible to work with Via Surgical's FasTouch cartridges (25PS cartridge).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
soft tissues
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The FasTouch Fixation System underwent a full battery of bench testing, animal testing, and biocompatibility testing to demonstrate its safe and effective performance in fixation of prosthetic material (e.g., hernia mesh) to soft tissues. In addition, clinical usability testing was conducted. It was concluded that the device is safe and effective for its intended use. Tests were performed with variety of market-cleared mesh types and sizes using the FasTouch Fixation System. In addition, tests were done in comparison to the predicate devices. Specifically, testing included: Device Cartridge loading and replacement (BT-011), Fixation strength evaluation (BT-012), Mesh compatibility and Integrity following fixation with the FasTouch Device (BT-013), Performance Evaluation (BT-014), Animal study for deployment and fixation including surgeons feedback, Clinical usability test.
All testing performed demonstrated that the FasTouch Fixation System is a safe and effective device for facilitating the fixation of soft tissue prosthetics during the laparoscopic repair of hernia and is considered substantially equivalent to its predicate devices.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4750 Implantable staple.
(a)
Identification. An implantable staple is a staple-like device intended to connect internal tissues to aid healing. It is not absorbable.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image contains the logo for Via Surgical. The logo consists of a stylized graphic to the left of the company name. The text "Via Surgical" is written in a clean, sans-serif font, with each letter clearly legible.
Pre Market Notification Submission - 510(k)
510(K) SUMMARY FasTouch Fixation System 510(k) Number K_132698
5.1 Company Name
Via Surgical Ltd. Mitzpe Kineret Street 22/1 Moshav Amirim, Amirim 20115, Israel Tel: +972-52-639-5765 Fax: +972-153-77-500-8214
5.2 Contact Person
Leo Basta NorthStar Biomedical Associates for Via Surgical Ltd. 93 Benefit Street Providence, RI 02904 617.834.9866 (phone) 401.454.1733 lbasta@northstarbiomedical.com
And/or
Orly Maor 25 A Sirkin Street Kfar-Saba 4442156, Israel Tel: 972-7453607 Fax: 972-153-9-7453607 oram.ma@gmail.com
5.3 Trade/Proprietary Name
FasTouch Fixation System
- 5.4 Classification Name Staple Implantable
Via Surgical 510(k) Rev. A
1
Image /page/1/Picture/1 description: The image contains the logo for Via Surgical. The logo consists of a stylized graphic to the left of the company name. The text "Via Surgical" is written in a clean, sans-serif font, with each letter clearly legible.
5.5 Product Code/Regulation No.
Implantable staple, product code: GDW, Regulation No. 878.4750.
- ર્ટ.6 Device Classification Class II
- 5.7 Panel
General & Plastic Surgery
રું. ક Predicate Devices
- Ethicon LLC SECURFSTRAP 5mm Absorbable Strap Fixation Device, l . cleared under K093845, (product code GDW, Regulation No. 878.475).
- Davol Inc. Bard PermaFix Fixation System, K092483 (product code 2. GDW, Regulation No. 878.475).
5.9 Intended Use
The FasTouch Fixation System is intended for fixation of prosthetic material to soft tissues in various minimally invasive and open surgical procedures such as hernia repairs.
5.10 Device Description
The FasTouch Fixation System is a manual laparoscopic surgical instrument which is intended to facilitate fixation of prosthetic material to soft tissue in laparoscopic or open surgical procedures such as ventral hernia repair. The FasTouch Fixation System is disposable, single-use system.
The Via Surgical's FasTouch Fixation System is designed to be inserted through a laparoscopic port sleeve but may be used during open surgical procedures as well. The FasTouch Fixation System is packaged in its unloaded state and contains a handle and a cartridge.
The FasTouch Handle is a multi-fire, sterile, single-use handle that is compatible to work with Via Surgical's FasTouch cartridges (25PS cartridge).
5.11 Performance Standards
No performance standards have been established for such device under Section 514 of the Federal Food, Drug, and Cosmetic Act.
Via Surgical 510(k) Rev. A
2
Image /page/2/Picture/1 description: The image shows the logo for Via Surgical. The logo consists of a stylized graphic to the left of the company name. The graphic is a black abstract shape, and the company name "Via Surgical" is written in a simple, sans-serif font.
5.12 Substantial Equivalence
Via Surgical Ltd. believes that the FasTouch Fixation System is substantially equivalent to the legally marketed predicate devices due to the following reasons:
A ) The same intended use and indications for use as the predicate devices.
B) All devices use a similar fixation technology to deliver the fasteners by compressing a trigger.
C) Similar fastener strap design to the fasteners used with the SecureStrap predicate and similar non-absorbable polymer material as used in the PermaFix predicate.
D) Similar technological characteristics to the predicate devices such as: trigger handle, penetration depth, spring load firing mechanism and shaft length.
E) Same principle of operation.
F) Similar materials.
As demonstrated in the completed battery of preclinical tests that were conducted by the company minor technological differences between the FasTouch Fixation System and the predicate devices do not raise new questions of safety and effectiveness. Any minor differences in technological characteristics have been tested and reported on in this notification and demonstrate that any differences do not adversely affect the safety, effectiveness, or intended performance of the device. Therefore, the FasTouch Fixation System is substantially equivalent to the legally marketed predicate devices. Testing included laboratory bench testing, biocompatibility testing, animal testing, and clinical usability testing.
5.13 Performance Characteristics of the FasTouch Fixation System
The FasTouch Fixation System underwent a full battery of bench testing, animal testing, and biocompatibility testing to demonstrate its safe and effective performance in fixation of prosthetic material (e.g., hernia mesh) to soft tissues. In addition, clinical usability testing was conducted. It was concluded that the device is safe and effective for its intended use. Tests were performed with variety of market-cleared mesh types and sizes using the FasTouch Fixation System. In addition, tests were done in comparison to the predicate devices. Specifically, testing included:
Via Surgical 510(k) Rev. A
3
Image /page/3/Picture/1 description: The image contains the logo for Via Surgical. The logo consists of a stylized graphic to the left of the company name. The graphic appears to be a stylized representation of a surgical tool or device. The text "Via Surgical" is written in a simple, sans-serif font.
- Device Cartridge loading and replacement (BT-011) .
- Fixation strength evaluation (BT-012) .
- Mesh compatibility and Integrity following fixation with the FasTouch . Device (BT-013)
- Performance Evaluation (BT-014) .
- Animal study for deployment and fixation including surgeons feedback ●
- . Clinical usability test
All testing performed demonstrated that the FasTouch Fixation System is a safe and effective device for facilitating the fixation of soft tissue prosthetics during the laparoscopic repair of hernia and is considered substantially equivalent to its predicate devices.
5.14 Conclusion
Via Surgical Ltd. believes that, based on the descriptive and test information provided in this submission, the FasTouch Fixation System is substantially equivalent to its predicate devices.
Via Surgical 510(k) Rev. A
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MI) 20993-0002
March 14, 2014
Via Surgical Ltd. % Mr. Leo Basta Northstar Biomedical Associates 93 Benefit Street Providence, Rhode Island 02904
Re: K132698
Trade/Device Name: Fastouch Fixation system Regulation Number: 21 CFR 878.4750 Regulation Name: Implantable staple Regulatory Class: Class II Product Code: GDW Dated: February 10, 2014 Received: February 11, 2014
Dear Mr. Basta:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976. the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you: however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
5
Page 2 - Mr. Leo Basta
forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers. International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
David Krause -S
Binita S. Ashar, M.D., M.B.A., F.A.C.S. for Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
INDICATIONS FOR USE STATEMENT
510(k) Number (if known):
Device Name: FasTouch Fixation System
Indications for Use:
The FasTouch Fixation System is intended for fixation of prosthetic material to soft tissues in various minimally invasive and open surgical procedures such as hernia repairs.
Prescription Use _ ✔ (Part 2) C.F.R. 801 Subpart D) AND/OR
Over-The-Counter Use (21 C.F.R. 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Peter L. Hudson -S 2014.03.14 09:43:16 -04'00'
Via Surgical 510(k) Rev. A